DB: 1:10,000; ELISA: 1:10,000; Immunoprecipitation: 1:150; Western Blot: 1:500.
Reactivity
Human, Monkey, Mouse, Rat
Immunogen
Synthetic peptide corresponding to Human CD4 aa 437-458 (C terminal). The selected peptide was post-synthetically modified to achieve highest antigenicity before couplingto carrier protein using hetero bifunctional cross linker for Immunogen preparation.
Host
Rabbit
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Purification
Affinity Purification
Concentration
0.55-0.75 µg/µL
Product Form
Liquid
Formulation
Supplied in a proprietary buffer (pH 7.4-7.8) containing 30% glycerol and 0.5% BSA.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Recombinant humanized monoclonal antibody to CD4 for use as a research grade Ibalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD4 for use as a research grade Tregalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD4 for use as a research grade Ibalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD4 for use as a research grade Tregalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.